SurgePays faces a critical September 14, 2026, deadline to regain compliance with Nasdaq’s $35 million minimum market value requirement. Failure to meet this threshold could trigger formal delisting proceedings. The company previously received a notice of non-compliance regarding its market value.
Ascendiant Capital analyst Edward Woo maintained a Buy rating on SurgePays. Woo raised the price target to $3.75 from $3.50. This revision reflects optimism in the company's outlook despite the current regulatory challenges.